1. Brassica Pharma recalls multiple lots of four eye ointments

   News item 09 March 2024 Pages: 1 - 1

2. Codeine linctus reclassified as prescription-only in UK

   News item 09 March 2024 Pages: 2 - 2

3. Pseudoephedrine-related PRES and RCVS

   News item 09 March 2024 Pages: 3 - 3

4. Rotavirus vaccine-related AEs in infants

   News item 09 March 2024 Pages: 4 - 4

5. Withania somnifera-related GI disorders and liver injury

   News item 09 March 2024 Pages: 5 - 5

6. Addition of ARSIs to ADT increases risk of fractures and falls

   Clinical study 09 March 2024 Pages: 6 - 6

7. Anticonvulsant use in pregnancy may not increase risk of epilepsy in children

   Clinical study 09 March 2024 Pages: 7 - 7

8. Cannabis use increases risk of cardiovascular disorders

   Clinical study 09 March 2024 Pages: 8 - 8

9. Carbamazepine, lamotrigine, valproate: comparing risks of adverse cardiovascular events

   Clinical study 09 March 2024 Pages: 9 - 9

10. Co-administration of bivalent mRNA COVID-19 and influenza vaccines: no new or unexpected safety concerns

    Clinical study 09 March 2024 Pages: 10 - 10

11. ICIs: safety profiles and risks of immune-related serious AEs

    Clinical study 09 March 2024 Pages: 11 - 11

12. In-utero exposure to antibiotics: risk of serious infections in first year of life

    Clinical study 09 March 2024 Pages: 12 - 12

13. Other adverse reaction research

    News item 09 March 2024 Pages: 13 - 13

14. Abatacept/ciclosporin/cyclophosphamide

    Case report 09 March 2024 Pages: 14 - 14

15. Abatacept/golimumab/methotrexate

    Case report 09 March 2024 Pages: 15 - 15

16. Aciclovir/Dexamethasone

    Case report 09 March 2024 Pages: 16 - 16

17. Adalimumab/azathioprine/unspecfied steroids

    Case report 09 March 2024 Pages: 17 - 17

18. Adalimumab/ciclosporin

    Case report 09 March 2024 Pages: 18 - 18

19. Adalimumab/methotrexate

    Case report 09 March 2024 Pages: 19 - 19

20. Adrenergic receptor agonists/nitroglycerin

    Case report 09 March 2024 Pages: 20 - 20

21. Afatinib/Furmonertinib

    Case report 09 March 2024 Pages: 21 - 21

22. Albuterol/tiotropium-bromide

    Case report 09 March 2024 Pages: 22 - 22

23. Albutrepenonacog-alfa/nonacog-alfa

    Case report 09 March 2024 Pages: 23 - 23

24. Alectinib/methotrexate

    Case report 09 March 2024 Pages: 24 - 24

25. Allopurinol

    Case report 09 March 2024 Pages: 25 - 25

26. Allopurinol

    Case report 09 March 2024 Pages: 26 - 26

27. Allopurinol

    Case report 09 March 2024 Pages: 27 - 27

28. Alteplase

    Case report 09 March 2024 Pages: 28 - 28

29. Ambrisentan/Sildenafil/Treprostinil

    Case report 09 March 2024 Pages: 29 - 29

30. Amikacin/gentamicin/vancomycin

    Case report 09 March 2024 Pages: 30 - 30

31. Aminocaproic-acid/Anti-inflammatories/Romiplostim

    Case report 09 March 2024 Pages: 31 - 31

32. Amiodarone

    Case report 09 March 2024 Pages: 32 - 32

33. Amiodarone

    Case report 09 March 2024 Pages: 33 - 33

34. Amiodarone/daptomycin/minocycline

    Case report 09 March 2024 Pages: 34 - 34

35. Amoxicillin

    Case report 09 March 2024 Pages: 35 - 35

36. Amoxicillin/clavulanic-acid

    Case report 09 March 2024 Pages: 36 - 36

37. Amoxicillin/clavulanic-acid/phenytoin

    Case report 09 March 2024 Pages: 37 - 37

38. Amoxicillin/clavulanic-acid/piperacillin/tazobactam

    Case report 09 March 2024 Pages: 38 - 38

39. Amphotericin-B

    Case report 09 March 2024 Pages: 39 - 39

40. Amphotericin-B/Methylprednisolone

    Case report 09 March 2024 Pages: 40 - 40

41. Amphotericin-B/prednisone

    Case report 09 March 2024 Pages: 41 - 41

42. Anakinra

    Case report 09 March 2024 Pages: 42 - 42

43. Anastrozole

    Case report 09 March 2024 Pages: 43 - 43

44. Anidulafungin

    Case report 09 March 2024 Pages: 44 - 44

45. Anthracyclines/cytarabine/tretinoin

    Case report 09 March 2024 Pages: 45 - 45

46. Anti-infectives/cefuroxime/ruxolitinib

    Case report 09 March 2024 Pages: 46 - 46

47. Antibacterials/ceftriaxone

    Case report 09 March 2024 Pages: 47 - 47

48. Antibacterials/Clobetasol

    Case report 09 March 2024 Pages: 48 - 48

49. Anticoagulants and antihypertensives

    Case report 09 March 2024 Pages: 49 - 49

50. Antineoplastic drugs

    Case report 09 March 2024 Pages: 50 - 50